News

5. September 2023

Dr. Juliane Fischer joins Dynamic42 as Marketing Manager

We are delighted to announce that Dr. Juliane Fischer has joined our team and will from now on heading all Marketing efforts at Dynamic42.

29. August 2023

Daria and Sophie join the Dynamic42 lab team as permanent members

Following their Master's studies, Daria and Sophie join our lab team as research assistants.

5. July 2023

Press Release | BMBF provides Millions in Funding for Thuringia’s ATHANA Alliance

The RUBIN Alliance "ATHANA" (antifungal therapy approaches with nanoparticle-based targeting of drugs) is developing innovative therapeutic approaches for the treatment of infectious diseases, in particular fungal infections.

13. June 2023

Press Release | Dynamic42 raises mid-seven-figure investment in Series A financing round

Innovative organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round.

17. April 2023

Press Release | Dynamic42 develops new generation of biotech chips for organ-on-chip technology

BC003: The special feature of the new chip is the spatial design with three culture chambers. This enables the cultivation of complex, three-dimensional tissue cultures.

7. March 2023

Press Release | New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software.

Scientists at the laboratory, Dynamic42 Academy

13. February 2023

Press Release | Dynamic42 Academy

Jena-based biotech company passes on expertise on future organ-on-chip technology to research institutions and companies

1. July 2022

Dynamic42 in the Wirtschaftspiegel

We were featured as a member of medways e.V. in Wirtschaftsspiegel.

28. March 2022

Interview with the magazine “Laborjournal”

In an interview with the trade journal "Laborjournal", our managing directors explain how the Dynamic42 biotech chips work and how the "mini-organs" used contribute to reducing animal experiments.